26
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Is POC-CCA a truly reliable test for schistosomiasis diagnosis in low endemic areas? The trace results controversy

      research-article
      1 , 1 , 2 , *
      PLoS Neglected Tropical Diseases
      Public Library of Science

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction In the last decade, development of point-of-care platforms (POCs) for diagnosis of infectious diseases or rapid tests (RTs) has increased in order to attend to the need for reliable diagnostic tests for surveillance of endemic areas. Also, preventive chemotherapy in areas without sophisticated resources has become more affordable according to some field studies [1,2]. The advantages of application of RTs such as POC-Schistosoma circulating cathodic antigen (CCA) are undeniable in community settings. But some evidence also pointed to other uses, like in institutional settings, by investigating active infections in susceptible populations like travelers, immigrants, and/or refugees [3,4]. Nonetheless, a great deal of discussion still remains toward the exclusive use of the RTs and/or POCs as tools for monitoring schistosomiasis in controlled areas or areas undergoing elimination. Despite the obvious advantages, the growing application of RTs has also shown some pitfalls. Use of novel approaches in the diagnosis of schistosomiasis: Controversial results When the first commercial version launched, POC-CCA acceptance was huge among field researchers. CCA can be detected by a labeled monoclonal antibody immobilized on the sample membrane. The solution then runs over the strip where the antigen–antibody complex attaches to another monoclonal antibody immobilized at the test line. The lateral flow assay is an easy to use test, which the first version worked by applying a single drop of urine with a buffer. Following 20 minutes of incubation, results were determined by visual reading (Schisto POC-CCA cassette based test; Rapid Medical Diagnostics, Pretoria, South Africa). Most data produced came from collaborative foreign research groups working in areas of moderate to high endemicity and populations infected with high parasite loads but also in low endemic areas as well as individuals with very light infection [5–10]. RTs and/or POCs may surpass conventional methods (such as the Kato-Katz test) as reliable diagnostic tools in moderate and high endemic areas. Yet variable results may also be found on a daily basis in these areas, and very low reactivity reactions in non–egg-excretors might misdiagnose active infection after praziquantel (PZQ) use [9]. Also, POC-CCA accuracy may be questionable in areas of S. haematobium mono infection or multiple Schistosoma infections [11–13]. But discussion becomes really intense when RTs are used in low parasite load and/or low endemic areas. Although several works consistently demonstrated that sensitivity, and also specificity, are compromised in low endemic areas, some new evidence claims that POC-CCA reliability and accuracy are high in areas of low prevalence [14–16]. Nonetheless, as in areas of high and moderate endemicity, residual reactivity (trace) was fairly demonstrated in individuals without active schistosomiasis both before and after (re)treatment in community settings with low parasite burden and/or low endemicity [16]. Usually, the bottleneck is the use of the low-sensitivity Kato-Katz test as a “gold standard.” Interpretation of trace as positive (presence of infection) or negative (absence of infection) creates lots of discussion about the validation of POC-CCA as a single test to replace Kato-Katz for the estimation of schistosomiasis prevalence in transmission areas. Particularly concerned with POC-CCA performance in low endemic areas, Clements and colleagues [17] evaluated trace results by applying Bayesian latent class analysis to improve the low sensitivity of the Kato-Katz and the so-called absence of a “gold standard.” In the same study, up-converting phosphor lateral flow circulating anodic antigen (UCP-LF CAA), a non-commercially available assay, was used to evaluate preselected trace-positive POC-CCA samples by assuming UCP-LF CAA was 100% specific. The results showed that POC-CCA outperformed Kato-Katz. However, considering trace as negative, Schistosoma active infection was missed in many cases. In contrast, trace as positive overestimated the prevalence. But by running UCP-LF CAA on selected trace-positive samples, the prevalence estimates from POC-CCA trace-positive samples should indeed represent the real prevalence in a lightly infected population. Recently, a new S. mansoni POC-CCA test became available, provided by only one manufacturer in the world. The new assay now uses only two drops of urine straight into a cassette instead of one drop of urine in addition to one drop of buffer as the recently discontinued previous version. The reading is done after 20 minutes like the older version. So far, no information was declared by the company regarding modifications on the test principle. Despite the successful removal of traces, the elimination of potential false positivity resulted in no detection of true positives. Therefore, individuals with active schistosomiasis were misdiagnosed as negative by the new test version in low endemic areas. In the past, custom-tailored kits were tested, aiming to overcome the debatable accuracy and performance of POC-CCA in a low-prevalence population of school children [18]. Because only limited information was disclosed by the manufacturers, one assumes that changes on test sensitivity were also performed since the last commercially available assay. One of the main reasons to adopt RTs as a diagnostic strategy is detection of active infection for surveillance purposes, including fast determination of prevalence in transmission areas and drug response. However, the POC-CCA for S. mansoni showed conflicting results depending on the area studied. In low endemic areas where low parasite loads or no egg-excretion predominates, POC-CCA was unsatisfactory as a solitary tool for diagnosis of active infections [15, 19]. Previous epidemiological studies in areas of high and moderate endemicity showed promising preliminary results during pretreatment with PZQ. However, persistence of very weak reactivity (trace) in the absence of egg excretion and/or other evidence of active infection could be seen in individuals treated with one to three rounds of PZQ [9]. Mwinzi and colleagues [20] showed that after the first round of PZQ use, 47% and 34% of POC-CCA reactive individuals ended up responding to second and third rounds of treatment, respectively, by becoming negative on POC-CCA. Nonetheless, more than 60% of retreated individuals still remained reactive. Other diagnostic tests had low agreement between pre- and post-therapy use, therefore the discussion remains about the usefulness of trace results. Recently, Coelho and colleagues [21] proposed optimization of POC-CCA in low–worm-burden samples by using lyophilization of urine as an antigen concentration method, showing that most of trace results turned negative and some negative samples became trace. In short, predefinition of trace as positive or negative may end up misleading test interpretation. In contrast, Prada and colleagues [22] addressed the true meaning of trace post-PZQ use and showed that POC-CCA seems to be a better predictor of post-treatment prevalence. Even trace results could be associated with true active infection. Following changes performed in RT manufacturing, as described above, very weak responses were swept out of the low endemicity areas, and no traces of “true” active infection could be detected. Now, the underscored results point to a possible underestimation of the real prevalence both pre- and post-treatments since traces disappeared. Without any consultation of the scientific community, the only available commercial test used so far in epidemiological studies changed its formulation and discontinued the previous test version (Schisto POC-CCA cassette based test; Rapid Medical Diagnostics, Pretoria, South Africa). No previous validation studies were performed in low endemic areas before commercial release of the test by the company. Also, the actual conflicting results do not permit decisions like the substitution of reference tests for POC-CCA. Conclusions and authors’ view RTs showed high accuracy and performance in moderate and high transmission areas. The tests in platforms of point-of-care to diagnose Schistosoma infections are an appealing solution for mapping and surveillance of transmission areas because of their main characteristics: user-friendly and relatively low price. However, consistent evidence showed limited application of RTs in schistosomiasis diagnosis in low endemic areas. Mostly, in those settings, low parasite burden predominates, which results in a decrease of diagnostic test accuracy. Moreover, the presence of trace reactivity is a real pitfall. POC-CCA very low intensity reactions may hide low parasite–load-induced infections. Therefore, removal of trace might result in no detection of Schistosoma infection pre- and post-PZQ use and, as a result, improvement of the test must be encouraged. However, testing should precede the use by national programs. As it is, the diagnosis of Schistosoma infection pre- and post-therapy based solely on RTs and/or POC may be compromised in areas of controlled or eliminated schistosomiasis. Strategies based on a single commercial product without prevalidation in both low endemicity areas and in institutional settings can be worrisome. Blinded changes in RT formulation may end up increasing disaster situations and confusion. Commercially available diagnostic tools should be tested exhaustingly before release for general use in transmission and nonendemic areas worldwide.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: found
          • Article: not found

          Application of a circulating-cathodic-antigen (CCA) strip test and real-time PCR, in comparison with microscopy, for the detection of Schistosoma haematobium in urine samples from Ghana.

          In the detection of parasitic infection, the traditional methods based on microscopy often have low sensitivity and/or specificity compared with the newer, molecular tests. An assay based on real-time PCR and a reagent strip test for detecting circulating cathodic antigen (CCA) have both now been compared with urine filtration and microscopy, in the detection of Schistosoma haematobium infections. Urine samples, obtained from 74 'cases' in areas of Ghana with endemic S. haematobium and 79 'controls' from non-endemic areas, were each checked using the three methods. With the results of the filtration and microscopy taken as the 'gold standard', real-time PCR was found to be 100% specific and 89% sensitive whereas the CCA strips were 91% specific and 41% sensitive. With the samples found to contain > or =50 eggs/10 ml (indicating relatively intense infections), the sensitivities of the PCR and CCA were higher, at 100% and 62%, respectively. As expected, egg counts were negatively correlated with the number of amplification cycles needed, in the PCR, to give a signal that exceeded the background (r=-0.38; P<0.01). Although the real-time PCR and CCA strip tests are very different, both show promise in the detection of S. haematobium infections. The PCR has optimal specificity and high sensitivity but the specificity of the CCA strips and the sensitivity of both tools could still be improved. A more thorough re-evaluation of the sensitivity and specificity of microscopy and these newer diagnostic methods, with an estimation of the cost-effectiveness of each technique, is recommended.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Schistosomiasis is more prevalent than previously thought: what does it mean for public health goals, policies, strategies, guidelines and intervention programs?

            Mapping and diagnosis of infections by the three major schistosome species (Schistosoma haematobium, S. mansoni and S. japonicum) has been done with assays that are known to be specific but increasingly insensitive as prevalence declines or in areas with already low prevalence of infection. This becomes a true challenge to achieving the goal of elimination of schistosomiasis because the multiplicative portion of the life-cycle of schistosomes, in the snail vector, favors continued transmission as long as even a few people maintain low numbers of worms that pass eggs in their excreta. New mapping tools based on detection of worm antigens (circulating cathodic antigen – CCA; circulating anodic antigen – CAA) in urine of those infected are highly sensitive and the CAA assay is reported to be highly specific. Using these tools in areas of low prevalence of all three of these species of schistosomes has demonstrated that more people harbor adult worms than are regularly excreting eggs at a level detectable by the usual stool assay (Kato-Katz) or by urine filtration. In very low prevalence areas this is sometimes 6- to10-fold more. Faced with what appears to be a sizable population of “egg-negative/worm-positive schistosomiasis” especially in areas of very low prevalence, national NTD programs are confounded about what guidelines and strategies they should enact if they are to proceed toward a goal of elimination. There is a critical need for continued evaluation of the assays involved and to understand the contribution of this “egg-negative/worm-positive schistosomiasis” condition to both individual morbidity and community transmission. There is also a critical need for new guidelines based on the use of these more sensitive assays for those national NTD programs that wish to move forward to strategies designed for elimination. Electronic supplementary material The online version of this article (doi:10.1186/s40249-017-0275-5) contains supplementary material, which is available to authorized users.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Accuracy of Urine Circulating Cathodic Antigen Test for the Diagnosis of Schistosoma mansoni in Preschool-Aged Children before and after Treatment

              Introduction Recognizing the public health impact of schistosomiasis and soil-transmitted helminthiasis, the World Health Organization (WHO) has set a minimum target for the control of morbidity due to these parasitic worm infections, urging member states to regularly treat at least 75% and up to 100%, of all school-aged children at risk of morbidity [1], [2]. As a result, many African countries have set up national plans of action for the control of schistosomiasis and soil-transmitted helminthiasis, and pursue school-based deworming campaigns [3], [4]. Experience and lessons from these programs are that they significantly reduce the prevalence and intensity of infection, and thus morbidity [5]–[8]. There is growing evidence that soil-transmitted helminths (Ascaris lumbricoides, hookworm, and Trichuris trichiura) and schistosome infections are acquired already in early childhood [9]–[14]. Hence, there is a need for effective and safe treatment of preschool-aged children, as their inclusion in preventive chemotherapy is being discussed [10], [11], [15], [16]. The intensity of infection with soil-transmitted helminths and schistosomes is age-dependent, usually showing a peak in school-aged children and adolescents [17], [18]. For schistosomiasis this might be due to cumulative and increasing water contacts of the school-aged child, combined with the maturation and increasing egg-laying capacity of schistosome worm pairs [11]. Hence, the majority of infected young children might excrete only a few eggs with their feces (for soil-transmitted helminths and Schistosoma mansoni) and their urine (for S. haematobium) [9], [11], [13], [17]. It is important to note that the Kato-Katz technique, which is widely used in endemic countries for the diagnosis of S. mansoni and soil-transmitted helminths, lacks sensitivity, particularly in areas of low endemicity, and for low-intensity infections (i.e., in young children or after treatment interventions) [19]–[22]. Hence, improved diagnostic methods for the accurate detection of S. mansoni in preschool-aged children, assessment of drug efficacy, and monitoring progress of control programs are desirable. Recent studies have shown that indirect diagnostic tests (e.g., point-of-care circulating cathodic antigen (POC-CCA)) have become valuable alternatives to direct parasitological methods for the diagnosis of S. mansoni [13], [23]. Note that the POC-CCA cassette test detects the presence of CCA (a schistosome glycoprotein) in host urine, after being regurgitated into the bloodstream by actively feeding worms, and successive clearance in the host's kidneys. Schistosome antigens (CCA and circulating anodic antigen (CAA)) can be detected in the serum and urine of infected individuals and their levels are sensitive and specific markers for the presence and intensity of infection [13], [23]–[26]. Circulating antigens disappear from serum and urine of schistosomiasis patients within a couple of weeks after successful treatment [24], [27]. Studies assessing a CCA urine dipstick and a POC-CCA cassette test in preschool-aged children in Uganda and Kenya, respectively, recommended these rapid tests as a useful technique for the detection of S. mansoni in that age group [11], [28], [29]. In our own research, conducted with school-aged children in south Côte d'Ivoire, we found that a single POC-CCA cassette test was similarly sensitive as triplicate Kato-Katz thick smears for the diagnosis of S. mansoni [26]. However, the physiological development and biological processes, such as absorption, distribution, metabolism, toxicity and, particularly, excretion are all age and setting dependent [30]. Moreover, the effect of geographical variations of S. mansoni strains on the performance of POC-CCA cassette test is poorly understood. Hence, there is a need to determine the accuracy of the POC-CCA cassette test in preschoolers from different settings as a diagnostic tool for S. mansoni, including its potential for drug efficacy evaluation, and monitoring of community effectiveness of control interventions. The current study was designed to assess the accuracy of the commercially available urine POC-CCA cassette test for the diagnosis of S. mansoni in preschool-aged children. We designed a 3-week longitudinal study with a treatment intervention, and determined the accuracy of the POC-CCA cassette test before and after the administration of praziquantel. Methods Ethics Statement Our study received ethical clearance from the Ministry of Health and Public Hygiene of Côte d'Ivoire (reference no. 4248/2010/MSHP/CNER). Local authorities in the study area (Azaguié, south Côte d'Ivoire) were informed about the objectives, procedures, and potential risks and benefits of the study. At study onset, a door-to-door information campaign was conducted, and all households in the area informed about the aims and procedures of the study. Written informed consent (or fingerprints of illiterate people) was obtained from parents/guardians of participating preschool-aged children. Treatment was administered to all preschool-aged children and their mothers, irrespective of their infection status. Participating preschool-aged children were treated with crushed praziquantel tablets at a dose of 40 mg/kg and the efficacy and safety of this intervention have been described elsewhere [31]. At the end of the study, anthelmintic treatment (single 40 mg/kg oral dose of praziquantel against schistosomiasis, and single 400 mg oral dose of albendazole against soil-transmitted helminthiasis) was offered to all villagers free of charge. Study Area and Population The study pursued a 3-week longitudinal design with a treatment intervention and was conducted between August and November 2011 in two villages located in the Azaguié district in south Côte d'Ivoire. The two villages, Azaguié Makouguié (geographical coordinates, 05°37′33″N latitude, 04°09′04″W longitude) and Azaguié M'Bromé (05°39′42″N, 04°08′38″W) are co-endemic for S. mansoni and S. haematobium [26], [31]. Subsistence farming is the main economic activity in both villages. Unprotected surface water bodies are frequently contacted due to the lack of tap water and other sources of clean water. Improved sanitary facilities are the exception rather than the norm. Our door-to-door census conducted in June 2011 revealed total populations of 931 people in Azaguié M'Bromé, and 783 people in Azaguié Makouguié. For the current study, emphasis is placed on preschool-aged children younger than 6 years in both villages (n = 367). Stool and Urine Collection Using records obtained from the mid-2011 census, a list of all children aged 0.05). S. mansoni and Soil-Transmitted Helminth Infections before Treatment Table 2 shows the baseline prevalence and intensity of S. mansoni infection, as assessed by Kato-Katz and POC-CCA. Among the 242 children with complete data records, 56 (23.1%) were found positive for S. mansoni by quadruplicate Kato-Katz thick smears. Most infections were of light intensity (n = 40; 71.4%), whereas 12 children (21.4%) had a moderate (100–399 EPG) and four children (7.1%) had a heavy infection (≥400 EPG). The group arithmetic mean FEC was 23.4 EPG (95% confidence interval (CI): 13.0–33.7 EPG). A single CCA(t−) test identified 83 children (34.3%) harboring active schistosome infections. 10.1371/journal.pntd.0002109.t002 Table 2 Baseline prevalence of helminths according to diagnostic approach (n = 242). Parasite Diagnostic approach No. of infected individuals % positive (95% CI) Infection intensity (%) Light Moderate Heavy Schistosomiasis Schistosoma mansoni Quadruplicate Kato-Katz thick smears 56 23.1 (17.6–28.3) 40 (71.4) 12 (21.4) 4 (7.1) Schistosoma mansoni (t−) Single POC-CCA cassette test (day 1) 83 34.3 (28.3–40.3) 40 (16.5) 14 (5.8) 29 (11.9) Schistosoma mansoni (t+) Single POC-CCA cassette test (day 1) 156 64.5 (58.4–70.5) 113 (46.7) 14 (5.8) 29 (11.9) Schistosoma haematobium Two urine filtrations 26 10.7 (6.8–14.7) 25 (96.2) n.d. 1 (3.8) Soil-transmitted helminths Trichuris trichiura Quadruplicate Kato-Katz thick smears 22 9.1 (1.9–12.7) 22 (100) 0 0 Hookworm Quadruplicate Kato-Katz thick smears 15 6.2 (3.1–9.3) 15 (100) 0 0 Ascaris lumbricoides Quadruplicate Kato-Katz thick smears 9 3.7 (1.3–6.1) 6 (66.7) 3 (33.3) 0 The study was carried out in Azaguié, south Côte d'Ivoire in August and September 2011. Duplicate Kato-Katz thick smears were prepared from each stool sample and a single POC-CCA cassette test was done on urine samples collected over two consecutive days. Infection intensities are based on thresholds put forth by WHO [1]. The POC-CCA test results were categorized as light (1+), moderate (2+), and heavy (3+). CI, confidence interval; n.d., not defined; POC-CCA, point-of-care circulating cathodic antigen; t−, trace negative; t+, trace positive. The youngest child infected with S. mansoni, as determined by the presence of S. mansoni eggs in stool using the Kato-Katz technique, was 8 months. According to the CCA(t−) test results, the earliest infection was observed in a child aged 3 months. According to quadruplicate Kato-Katz thick smears before treatment, among the 242 preschool-aged children with complete data records, 22 (9.1%), 15 (6.2%) and nine (3.7%) were positive for T. trichiura, hookworm and A. lumbricoides, respectively (Table 2). Hookworm and T. trichiura infections were exclusively of light intensity (<2,000 EPG and <1,000 EPG, respectively), whereas a third of the A. lumbricoides infections were of moderate intensity (5,000–49,999 EPG). Among the 40 children who were infected with S. mansoni according to a single CCA(t−) test, but showed no S. mansoni eggs in any of the four Kato-Katz thick smears, three (7.5%), two (5.0%), and two (5.0%) children were positive for T. trichiura, S. haematobium and A. lumbricoides, respectively. None of these children were infected with hookworm. S. haematobium Infections before Treatment Among 242 children at the baseline survey, 26 were infected with S. haematobium, giving a prevalence of 10.7% (Table 2). Only one child, a 5-year-old girl, had a heavy infection (128 eggs/10 ml of urine). There was no significant association between CCA(t−) results expressed as binary variable (presence/absence of disease) and S. haematobium egg counts (OR = 1.2; p = 0.81). Similarly, no significant association was found between CCA(t+) results expressed as binary variable (presence/absence of disease) and S. haematobium egg counts (OR = 1.2; p = 0.11). Diagnostic Accuracy before Treatment Figure 2 shows the correlation between the intensity of S. mansoni infection determined by quadruplicate Kato-Katz thick smears, as expressed in EPG, and the CCA(t−) test shown in color scores. We observed a correlation between the color intensity of CCA(t−) test bands and EPG values (odds ratio (OR) = 1.2, p = 0.04). 10.1371/journal.pntd.0002109.g002 Figure 2 Correlation between S. mansoni egg counts and CCA test color reaction scores. This figure shows the correlation between S. mansoni eggs per gram of stool (EPG) values, as determined by quadruplicate Kato-Katz thick smears, and a single urine CCA cassette test with ‘trace’ considered as negative result (negative (0), 1+, 2+, and 3+. Comparing the two different methods used for the diagnosis of S. mansoni, we found moderate agreement between a single CCA(t−) test and quadruplicate Kato-Katz thick smears (κ = 0.47, p<0.001, Table 3). The agreement between duplicate CCA(t−) and quadruplicate Kato-Katz thick smears was only fair (κ = 0.36, p<0.001). Agreement between the two methods was weaker when considering trace results as positive in the urine CCA cassette test. 10.1371/journal.pntd.0002109.t003 Table 3 Agreement between Kato-Katz technique and POC-CCA cassette test for the diagnosis of S. mansoni. Quadruplicate Kato-Katz thick smears κ* p POC-CCA cassette test results Test result Positive Negative Single POC-CCA test (t−) Positive 43 40 Negative 13 146 0.47 <0.001 Duplicate POC-CCA tests (t−) Positive 46 63 Negative 10 123 0.36 <0.001 Single POC-CCA test (t+) Positive 52 104 Negative 4 82 0.23 <0.001 Duplicate POC-CCA tests (t+) Positive 53 132 Negative 3 54 0.13 <0.001 The study was carried out in Azaguié, south Côte d'Ivoire in August and September 2011. * κ indicating kappa; κ<0, no agreement; κ = 0–0.2, poor agreement; κ = 0.21–0.4, fair agreement; κ = 0.41–0.6, moderate agreement; κ = 0.61–0.8, substantial agreement; κ = 0.81–1.0, almost perfect agreement [35]. t−, trace negative; t+, trace positive. According to our ‘gold’ standard, the sensitivity of a single CCA(t−) test (69.7%) was considerably higher than that of a single (28.3%) or quadruplicate Kato-Katz thick smears (47.5%, Table 4). Also the NPV of a single CCA(t−) test (77.4%) was higher than that of a single (59.1%) or quadruplicate Kato-Katz (65.9%). The sensitivity and NPV of a single CCA(t+) test were higher than those of quadruplicate Kato-Katz and single CCA(t−) (sensitivity: 89.1%; NPV: 84.9%). The specificity of the Kato-Katz technique and CCA(t−) was 100% by definition, whereas the specificity of a single CCA(t+) was considerably lower (59.3%). 10.1371/journal.pntd.0002109.t004 Table 4 Sensitivity, specificity, and negative predictive value (NPV) of different approaches for the diagnosis of S. mansoni. Before treatment (n = 242) After treatment (n = 86) Combined results as ‘gold’ standard* Sensitivity Specificity NPV Sensitivity Specificity NPV (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI) Single Kato-Katz thick smear 28.3 (20.5–37.3) 100 (97.0–100) 59.1 (52.1–65.9) 4.0 (0.1–20.4) 100 (94.1–100) 71.8 (61.0–81.0) Duplicate Kato-Katz thick smears 36.1 (27.5–45.4) 100 (97.0–100) 61.8 (54.7–68.6) 4.0 (0.1–20.4) 100 (94.1–100) 71.8 (61.0–81.0) Triplicate Kato-Katz thick smears 42.9 (33.8–52.3) 100 (97.0–100) 64.4 (57.2–71.2) 4.0 (0.1–20.4) 100 (94.1–100) 71.8 (61.0–81.0) Quadruplicate Kato-Katz thick smears 47.5 (38.3–56.8) 100 (97.0–100) 65.9 (58.6–72.7) 8.0 (0.9–26.0) 100 (94.1–100) 72.6 (61.8–81.8) Single POC-CCA cassette test (t−) 69.7 (60.7–77.8) 100 (97.0–100) 77.4 (70.1–83.6) 80.0 (59.3–93.2) 100 (94.1–100) 92.4 (83.2–97.5) Duplicate POC-CCA cassette test (t−) 91.6 (85.1–95.9) 100 (97.0–100) 92.5 (86.6–96.3) 96.0 (79.6–99.9) 100 (94.1–100) 98.4 (91.3–100) Single POC-CCA cassette test (t+) 89.1 (81.2–93.5) 59.3 (50.1–68.1) 84.9 (75.5–91.7) 84.0 (63.9–95.5) 77.0 (64.5–86.8) 92.2 (81.1–97.8) Duplicate POC-CCA cassette test (t+) 97.5 (92.8–99.5) 99.5 (90.1–100) 93.0 (83.0–98.1) 100 (86.3–100) 96.6 (93.1–100) 100 (90.3–100) The study was carried out in Azaguié, south Côte d'Ivoire in August and September 2011. Sensitivity, specificity, and NPV of different approaches for the diagnosis of S. mansoni were assessed before and after praziquantel administration. * Combined results of quadruplicate Kato-Katz thick smears and duplicate POC-CCA cassette tests with trace results considered as negative. CI, confidence interval, t−, trace negative; t+, trace positive. Diagnostic Accuracy after Treatment Among the 86 individuals who had complete data records after treatment, S. mansoni eggs were detected by Kato-Katz from 22 (25.6%) individuals during the baseline cross-sectional survey. A single POC-CCA, considering trace results as negative, revealed 34 preschoolers (39.5%) with an infection. Considering trace results as positive, then a considerably higher number of preschoolers were classified as positive (n = 56, 65.1%). After treatment, among these 86 children, eggs of S. mansoni were only found in two (2.3%) individuals. A single urine CCA(t−) cassette test revealed 20 children (23.3%) with S. mansoni, whereas CCA(t+) found 35 (40.7%) infections. At the 3-week posttreatment evaluation, and considering our ‘gold’ standard (combined results of quadruplicate Kato-Katz thick smears plus duplicate urine CCA(t−) cassette tests), a single CCA(t−) revealed a sensitivity and NPV of 80.0% and 92.4%, respectively (Table 4). Single and even quadruplicate Kato-Katz thick smears showed very low sensitivity (4.0% and 8.0%, respectively) and only moderate NPV (71.8–72.6%). In our cohort of 86 children, when considering the combined results from both sampling days, 27 children had a positive POC-CCA cassette test result, traces included. Among these children, 20 were S. mansoni egg-negative at the baseline survey, whereas the seven infected children had baseline FECs ranging between 6 and 450 EPG. When considering POC-CCA trace results as negative, 24 children were still found with a positive POC-CCA cassette test. Among them, 21 children were egg-negative, whereas the three infected children showed baseline FECs ranging between 132 and 588 EPG. Hence, regardless of whether POC-CCA trace results were considered positive or negative, more than three-quarter of the children found positive with the POC-CCA cassette test at the posttreatment follow-up were egg-negative at the baseline survey. Day-to-Day Variability of POC-CCA Cassette Test Scores Table 5 shows the day-to-day variability of the POC-CCA cassette test scores before (n = 242) and 3 weeks after the administration of praziquantel (n = 86). At baseline 156 (64.5%) and 145 (59.9%) were found CCA positive on day 1 and day 2, respectively. After treatment, 35 (40.7%) children on day 1 and 32 (37.2%) children on day 2 showed a positive POC-CCA test. Comparing POC-CCA cassette test results from both days, revealed no statistically significant difference in test results before (p = 0.619) and after (p = 0.756) treatment. 10.1371/journal.pntd.0002109.t005 Table 5 Number of preschool-aged children falling in each POC-CCA test score before and after treatment. POC-CCA cassette test score Before treatment (n = 242) After treatment (n = 86) Negative (0) Trace 1+ 2+ 3+ Negative (0) Trace 1+ 2+ 3+ Day 1 86 73 40 14 29 51 15 10 9 1 Day 2 97 65 28 23 29 54 17 9 3 3 Combined scores (days 1 and 2)a 105 28 50 27 32 59 3 15 7 2 Higher score (either day 1 or day 2)b 57 76 47 23 39 35 31 8 8 4 n = 86, Day 1: first day of urine collection, Day 2: second day of urine collection. a Combined POC-CCA cassette test (days 1 and 2), as defined in Table 1. b The higher POC-CCA cassette test score from either day 1 or day 2 was considered as final score. There was relatively little day-to-day variation, both before and after treatment. For example, before treatment, about half of the paired POC-CCA test results showed the same scores, whereas 127 (52.5%) children had discordant scores, with the highest discrepancy observed between negative and trace results. Considering trace results as negative, the percentage of discordant results decreased to 22.7%. In the posttreatment survey, none of the children with duplicate POC-CCA cassette tests performed showed 3+ scores on both days. Discordant POC-CCA test scores between days 1 and 2 were found in slightly more than half of the children (n = 44, 51.2%) with the highest number of discordant results between negative and trace results. The concordance between POC-CCA cassette test scores from days 1 and 2 increased with infection intensity (based on POC-CCA cassette test band color), both before and after treatment (Table S1). Among those 86 preschool-aged children who had complete data records before and after treatment, and considering the higher of the two color reactions in the duplicate POC-CCA tests as the final score showed that the number of tests scored 3+ before treatment decreased by 76.5% following treatment. A decrease of 22.5% of POC-CCA tests scored as trace was observed 3 weeks posttreatment. Among seven preschool-aged children scored as trace-positive before treatment, four became CCA-negative following treatment, whereas the remaining three were diagnosed CCA-positive (two children with 1+ and one child with 2+). Nine (16.1%) children among the 56 children detected with CCA (trace included) had unchanged test scores after treatment. The number of children found CCA-negative increased sharply 3 weeks after a single dose of praziquantel, with a particularly steep decrease of heavy infections (χ2 = 6.50, p = 0.011) (Figure 3). 10.1371/journal.pntd.0002109.g003 Figure 3 Frequency of CCA test scores before (n = 242) and after praziquantel administration (n = 86). The frequency of the CCA test scores (0, 1+, 2+, and 3+) before and after treatment with praziquantel was determined based on combined scores from days 1 and 2, as show in Table 1. Note that trace results were considered as negative. Test Requirements of POC-CCA Cassette and Kato-Katz Table 6 summarizes key test requirements and compares them between Kato-Katz (standard test) and POC-CCA (newly developed test) for the diagnosis of S. mansoni. Important test requirements include the ease of obtaining and analyzing the samples, cost considerations, and diagnostic accuracy. 10.1371/journal.pntd.0002109.t006 Table 6 Comparison of test requirements of POC-CCA cassette test and Kato-Katz technique. Test requirement POC-CCA cassette test Kato-Katz technique Sample Urine Stool Stage of worm detected Immature and adult worms through antigens Adult worms through eggs Number of sample needed for accurate diagnosis One sample, even in low endemicity setting Several samples, especially in low endemicity setting Sample collection Straightforward Difficult, reluctance to provide stool, especially among adults Time spent to obtain test result at the laboratory 25 min Several hours Skill of the person who performs the test Non-specialized personnel Specialized personnel Logistic Car for transport, POC-CCA test kit Car for transport, Kato-Katz kit, microscope, microscope slide, electricity No detailed requirements of each test are mentioned in this table, but the main requirements of each test are emphasized. Discussion There is growing awareness that in high endemicity settings, schistosomiasis already affects preschool-aged children, and hence these young children might need to be included in deworming campaigns [11], [13]–[16]. The Kato-Katz technique has been the backbone of intestinal schistosomiasis (and soil-transmitted helminthiasis) diagnosis in epidemiological studies for decades. However, it shows a low sensitivity for detecting low-intensity infections, which are commonly seen in young children and in communities undergoing regular treatment [21], [28], [36]. Recent studies have shown that a commercially available, urine-based POC-CCA cassette test is a promising method for the diagnosis of S. mansoni in preschoolers and school-aged children [13], [23], [26], [28], [29], [37], [38]. In the present work, we investigated the accuracy of this POC-CCA cassette test in preschool-aged children from south Côte d'Ivoire before and after administration of a single oral dose of praziquantel (40 mg/kg) and compared its performance to that of multiple Kato-Katz thick smears. We found that a single POC-CCA is more sensitive than quadruplicate Kato-Katz thick smears before and 3 weeks after praziquantel treatment. The intensity of a positive CCA test band reaction was significantly correlated with the S. mansoni egg burden quantified by the Kato-Katz technique. There was a sharp decrease of CCA tests scored 3+ after treatment and an increase in tests scored negative or trace. The youngest child identified as infected with S. mansoni applying the POC-CCA cassette test was 3 months old. Eggs in stool examined with the Kato-Katz method were only detected in children aged 8 months and above. Our results corroborate recent findings from Kenya and Uganda, where CCA tests detected S. mansoni infections in preschool-aged children considerable earlier and at higher frequency than the Kato-Katz technique and an enzyme-linked immunosorbent assay (ELISA) kit to test for host antibodies to soluble egg antigens [13], [28], [29]. The results reported here also extend on our own recent observations in the same study area and that of other groups made elsewhere that urine POC-CCA tests show a considerably higher sensitivity than the widely used Kato-Katz technique for the diagnosis of S. mansoni in school-aged children [23], [26], [38]. As confirmed in the present study, the prevalence and intensity of Schistosoma infections in preschool-aged children is rather low [9], [11], [13], [31]. Hence, the Kato-Katz and other direct diagnostic methods have limitations when it comes to accurate individual diagnosis. Moreover, the consistency of stools in very young children is mostly diarrheic what renders the preparation of Kato-Katz thick smears difficult, which further challenges an accurate diagnosis. The constrains of using diarrheic stool as well as stool of breastfed infants for helminth diagnosis has been reported elsewhere [39], [40]. In that respect, one needs to consider that in the humid tropics, viral, bacterial, and multiple species parasitic infections causing diarrhea are very common [41]–[43], and that preschool-aged children are particularly prone to such infections [42], [44]. Hence, the Kato-Katz technique has shortcomings for helminth diagnosis in this age-group. The implementation of large-scale schistosomiasis control programs that are based on preventive chemotherapy reduces the prevalence and, most importantly, the intensity of Schistosoma infections [4], [5], [45]. Hence, the endemicity is lowered, which goes hand-in-hand with a reduced accuracy of the Kato-Katz technique [22], [46]. In view of recent discussions regarding schistosomiasis elimination [47], the need for highly sensitive and specific diagnostic tools for the diagnosis of S. mansoni and other Schistosoma species after extensive preventive chemotherapy campaigns and additional interventions cannot be emphasized enough. However, some weaknesses seem to go against the use of POC-CCA as a diagnostic tool for control programs. First, the Kato-Katz method allows for diagnosis of other helminth infections (e.g., soil-transmitted helminthiasis), which commonly co-exist where schistosomiasis is endemic. Second, the Kato-Katz technique provides a quantitative measure to the infections, which guide the control program interventions. Third, the cost of a single POC-CCA cassette (approximately US$ 1.75) is similar to the total costs of performing a single Kato-Katz thick smear in epidemiological surveys (US$ 1.7) [48], [49]. Hence, the costs for individual diagnosis currently limit the use and attractiveness for program managers for larger-scale applications. For individual diagnosis, however, it should be noted that the costs largely depend on the patient's economical situation. Our finding of very young children diagnosed with S. mansoni when using the urine POC-CCA cassette test (3 months old), and only 5 months later when using the Kato-Katz technique raises an alarm bell. Current control programs focus on the school-aged population (usually starting at an age of 5–6 years), and hence a considerable number of infected children might be restrained from treatment for perhaps 3–4 years. Recent studies discussed the potential impact of early infections that remain untreated for several years on child health due to the cumulative effect of repeated infections [23], [50]–[52]. Our observations are also important from a surveillance point of view. Indeed, first the POC-CCA test revealed the age of first S. mansoni infection several months earlier than the Kato-Katz technique and, second, we found that three-quarter of the people who were CCA-positive at follow-up were egg-negative at baseline. It seems that these children were infected with immature worms that praziquantel was not able to kill. Hence, despite the aforementioned limits of the POC-CCA cassette test, some advantages deserve to be highlighted. First, POC-CCA is based on simple-to-use urine test, which can be performed by non-specialized personnel. Hence, it can be employed in remote rural areas that lack access to the power grid by minimally trained people (Table 6). Second, collection of urine samples for POC-CCA is more straightforward and less invasive than collection of stool for Kato-Katz thick smears. The time spent from the field (sample collection; urine for POC-CCA cassette test versus stool for Kato-Katz thick smears) to the laboratory (implementation; at least 25 min for POC-CCA cassette test versus several hours for Kato-Katz thick smears) places the POC-CCA in a favorable position. Third, a POC-CCA test is able to detect prepatent infections, whereas the Kato-Katz technique can only detect patent infections. Note that de Water and colleagues, in the mid-1980s, studying ultrastructural localization of CCA in the digestive tract of various life-cycle stages of S. mansoni showed that the antigens are present in the gut of adult worms, as well as in the primordial gut cells of cercariae aged 3.5 weeks [53]. In addition, a study implemented by van Dam and colleagues 10 years later on in vitro and in vivo excretion of CAA and CCA by developing schistosomula and adult worms showed that during the first days of S. mansoni development more CAA than CCA was excreted, while after one week the trend was reversed [25]. Taken together, the POC-CCA cassette test is an adequate and most useful tool for rapid identification of infected individuals and high-risk communities that warrant interventions at the individual patient level and at the community level with the goal to lower morbidity and transmission of schistosomiasis. Efforts might thus be warranted by the United Nations through its agencies to allow extension of the use of POC-CCA tests in schistosome-endemic areas where financial resources are often limited. Our study shows that the number of positives determined by POC-CCA after treatment is considerably higher than that revealed by quadruplicate Kato-Katz thick smears. Indeed, the Kato-Katz technique found a very low prevalence after treatment (2.3%), whereas POC-CCA test results revealed several-fold higher prevalences (23.3% considering trace results as negative and 40.7% considering trace results as positive). These differences might be explained by the following reasons. First, the Kato-Katz technique is underestimating the prevalence due to very low infection intensities after treatment [54]. Second, in the current study, Kato-Katz thick smears were read shortly after slide preparation (within 30–60 min). Prompt microscopic examination of Kato-Katz thick smears is recommended for the concurrent diagnosis of soil-transmitted helminths, particularly hookworm [20], but the optimal detection of S. mansoni eggs is after clearing the slides for 24 hours [55]. On the other hand, the POC-CCA test might overestimate the prevalence (i.e., in case CCA is still excreted in urine more than 3 weeks after treatment despite the death of adult worms). Studies conducted to date are inconclusive on when exactly CCA is eliminated from urine below detection limits [25], [56], [57]. In view of the aforementioned limitations of our direct parasitological approach, it is conceivable that CCA-positive, egg-negative cases are false-negatives based on the Kato-Katz technique [33]. Assessing the converting proportion of POC-CCA test color band scores after treatment, we observed a significant increase of negative scores and decrease of trace and 3+ scores, despite only considering the combined score per individual over two test days. Since we also found that the FECs detected with the Kato-Katz method correlate with the test band color intensity, the POC-CCA test might indeed reveal formerly heavily infected individuals as still positive. In light of the absence of a real ‘gold’ standard in our study, future investigations using highly sensitive and specific diagnostic methods (i.e., a polymerase chain reaction (PCR) [58], or detection of CAA by an up-converting phosphor technology (UPT)-based lateral flow (LF) assay [59]) are of need to investigate the true accuracy of a urine CCA cassette test after treatment, and hence its applicability for monitoring the success of schistosomiasis control programs. In conclusion, a single POC-CCA urine cassette test appears to be more sensitive than multiple Kato-Katz thick smears for the diagnosis of S. mansoni in preschool-aged children. It is therefore an appropriate tool for the rapid identification of S. mansoni-infected individuals, including preschool-aged children, and of high-risk communities before the onset of control interventions. Its applicability to accurately assess infections a few weeks after praziquantel administration needs further investigation and comparison with highly sensitive and specific diagnostic tools. Supporting Information Alternative Language Abstract S1 Translation of the Abstract into French by Jean T. Coulibaly. (DOC) Click here for additional data file. Checklist S1 STARD Checklist. (PDF) Click here for additional data file. Table S1 Concordance between POC-CCA test scores from consecutive days 1 and 2 at individual level before and after treatment. (DOC) Click here for additional data file.
                Bookmark

                Author and article information

                Contributors
                Role: ConceptualizationRole: Writing – original draftRole: Writing – review & editing
                Role: ConceptualizationRole: Writing – original draftRole: Writing – review & editing
                Role: Editor
                Journal
                PLoS Negl Trop Dis
                PLoS Negl Trop Dis
                plos
                plosntds
                PLoS Neglected Tropical Diseases
                Public Library of Science (San Francisco, CA USA )
                1935-2727
                1935-2735
                8 November 2018
                November 2018
                : 12
                : 11
                : e0006813
                Affiliations
                [1 ] Departmento de Imunologia, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
                [2 ] Serviço de Doenças Infecciosas e Parasitárias, Hospital Universitário Clementino Fraga Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
                George Washington University, UNITED STATES
                Author notes

                The authors have declared that no competing interests exist.

                Article
                PNTD-D-18-00790
                10.1371/journal.pntd.0006813
                6224048
                30408030
                db1c95d9-1c9a-42a0-a2d0-dc3dfd1f1d96
                © 2018 Peralta, Cavalcanti

                This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                Page count
                Figures: 0, Tables: 0, Pages: 5
                Funding
                The authors received no specific funding for this work.
                Categories
                Viewpoints
                Medicine and Health Sciences
                Parasitic Diseases
                Helminth Infections
                Schistosomiasis
                Medicine and Health Sciences
                Tropical Diseases
                Neglected Tropical Diseases
                Schistosomiasis
                Medicine and Health Sciences
                Parasitic Diseases
                Medicine and Health Sciences
                Diagnostic Medicine
                Biology and Life Sciences
                Anatomy
                Body Fluids
                Urine
                Medicine and Health Sciences
                Anatomy
                Body Fluids
                Urine
                Biology and Life Sciences
                Physiology
                Body Fluids
                Urine
                Medicine and Health Sciences
                Physiology
                Body Fluids
                Urine
                Biology and Life Sciences
                Organisms
                Eukaryota
                Animals
                Invertebrates
                Helminths
                Schistosoma
                Schistosoma Mansoni
                Medicine and Health Sciences
                Epidemiology
                Biology and Life Sciences
                Organisms
                Eukaryota
                Animals
                Invertebrates
                Helminths
                Schistosoma
                Biology and Life Sciences
                Physiology
                Immune Physiology
                Antibodies
                Monoclonal Antibodies
                Medicine and Health Sciences
                Physiology
                Immune Physiology
                Antibodies
                Monoclonal Antibodies
                Biology and Life Sciences
                Immunology
                Immune System Proteins
                Antibodies
                Monoclonal Antibodies
                Medicine and Health Sciences
                Immunology
                Immune System Proteins
                Antibodies
                Monoclonal Antibodies
                Biology and Life Sciences
                Biochemistry
                Proteins
                Immune System Proteins
                Antibodies
                Monoclonal Antibodies

                Infectious disease & Microbiology
                Infectious disease & Microbiology

                Comments

                Comment on this article